Smartphone-delivered Scheduled Smoking With Compliance Facilitation as an Adjunct Cessation Therapy: a Feasibility Study - Trial NCT05763771
Access comprehensive clinical trial information for NCT05763771 through Pure Global AI's free database. This phase not specified trial is sponsored by M.D. Anderson Cancer Center and is currently Not yet recruiting. The study focuses on Smoking. Target enrollment is 75 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
M.D. Anderson Cancer Center
Timeline & Enrollment
N/A
Aug 31, 2023
Dec 01, 2026
Primary Outcome
Application (App) Usability Questionnaire
Summary
To collect user experience data for a smartphone app that is designed to help people reduce
 or quit smoking and to learn if the app, combined with nicotine patches, can help people quit
 smoking.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05763771
Non-Device Trial